The National Centre for Infectious Diseases (NCID), previously known as the Communicable Disease Centre (Abbreviation: CDC), is a national public health institute under the Ministry of Health of Singapore
The Latest Bing News on:
National Centre for Infectious Diseases Research
- Until two years ago, mRNA vaccines had never been approved. Now, vast research offers hope in treating more than COVID-19
Faster to produce than conventional vaccines, the potential applications of synthetic mRNA to prevent illness and treat diseases seems nearly limitless ...
- Multi-purpose pandemic centre soon in Electronics City
BENGALURU: The Karnataka government will soon set up a Pandemic Centre, a Longevity Centre and a Bio Centre at the Bangalore Bioinnovation Centre (BBC) in Electronics City. Announ ...
- Researchers warn against national strategies for a "new normal" of life with COVID-19
Researchers are warning U.S. leaders and health officials against national strategies for a "new normal ... for severe and inequitable outcomes of NCDs and future infectious disease pandemics." In ...
- Rapid Diagnostics Market: Meticulous Research® Reveals Why This Market is Growing at a CAGR of 1.4% to Reach $26.40 Billion by 2029
Meticulous Research ®, in its latest publication on the ... Similarly, there is a large prevalence of infectious diseases in China. According to China’s Centre for Disease Control (CCDC), the country ...
- Infectious disease expert urges Australians to book in for a vaccine to avoid flu and COVID-19 'double whammy'
Professor Kristine McCartney, the Director of the National Centre for Immunisation Research and Surveillance (NCIRS), said it is possible Australians can be affected with both diseases - dubbed ...
The Latest Google Headlines on:
National Centre for Infectious Diseases Research
The Latest Bing News on:
National Centre for Infectious Diseases Discovery
- Until two years ago, mRNA vaccines had never been approved. Now, vast research offers hope in treating more than COVID-19
Faster to produce than conventional vaccines, the potential applications of synthetic mRNA to prevent illness and treat diseases seems nearly limitless ...
- ProMIS Neurosciences Announces First Quarter 2022 Results
ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF) (“ProMIS” or the “Company”), a biotechnology company focused on the discovery and development of antibody therapeutics targeting misfolded proteins ...
- 54gene Completes Initial Phase of the Landmark Nigerian 100K Genome Project
The prevalence of NCDs is projected to become higher than that of infectious diseases in Africa ... Research (NIMR), the National Biotechnology Development Agency's Centre for Genomics Research ...
- 54gene Completes Initial Phase of the Landmark Nigerian 100K Genome Project
The consortium, which is made up of scientists from 54gene, the Nigerian Institute of Medical Research, and the Center for Genomics Research and Innovation at the National Biotechnology ...
- Building scientific talent in the Global South can help prevent future public health crises
Major developments in HIV prevention, treatment, and vaccine development have come from scientists who got their start in the U.S. National ... Centre of Excellence for Genomics of Infectious ...
